Home
Live Updates
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results : comparemela.com
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
Achieved $50.3 million in total net revenue and $48.1 million in net product revenue for the first quarter of 2024, representing year over year growth of approximately 46% and 40% respectively, and...
Related Keywords
Canada ,
Maryland ,
United States ,
Rockville ,
Canadian ,
Peter Greenleaf ,
Clinical Program ,
Nasdaq ,
Aurinia Pharmaceuticals Inc ,
Company Annual Report On Form ,
Company Quarterly Report On Form ,
Share Repurchase Program ,
Exchange Commission Electronic Document Gathering ,
Aurinia Pharmaceuticals ,
Chief Executive Officer ,
Three Months Ended March ,
Condensed Consolidated Statement ,
Cash Flows ,
Quarterly Report ,
Annual Report ,
Canadian Securities Administrator System ,
Electronic Document Analysis ,
Exchange Commission ,
Electronic Document Gathering ,
Retrieval System ,
Months Ended March ,
Markets ,
comparemela.com © 2020. All Rights Reserved.